Related Experiment Video

Updated: Aug 1, 2026

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS
08:38

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS

Published on: November 8, 2015

Adverse reactions to trimethoprim-sulfamethoxazole in hemophiliacs

K Nahum1, P Saidi, H C Kim

  • 1Department of Medicine, University of Medicine and Dentistry of New Jersey, New Brunswick 08903-0019.

American Journal of Hematology
|February 1, 1988
PubMed

Insights

Adverse reactions to trimethoprim-sulfamethoxazole are common in patients with acquired immunodeficiency syndrome (AIDS). Caution is advised when prescribing this antibiotic to hemophiliacs due to observed severe toxicities, even before AIDS diagnosis.

Area of Science:

  • Infectious Diseases
  • Hematology
  • Pharmacology

Background:

  • Trimethoprim-sulfamethoxazole is frequently associated with adverse reactions in patients diagnosed with acquired immunodeficiency syndrome (AIDS).
  • Hemophiliacs represent a population at increased risk for developing AIDS.
  • Understanding drug toxicities in at-risk populations is crucial for patient safety.

Observation:

  • Severe toxicities were observed in three hemophiliac patients receiving trimethoprim-sulfamethoxazole.
  • These severe reactions occurred prior to the clinical manifestation of AIDS in the affected individuals.
  • The observed toxicities highlight potential drug-specific risks in this patient group.

Findings:

  • Hemophiliacs may experience severe adverse reactions to trimethoprim-sulfamethoxazole.
  • The risk of toxicity exists even in individuals not yet diagnosed with AIDS.
  • This suggests a heightened susceptibility in hemophiliacs irrespective of overt AIDS stigmata.

Implications:

  • Clinicians should exercise caution when prescribing trimethoprim-sulfamethoxazole to hemophiliacs.
  • Consideration of alternative antibiotics may be warranted for hemophiliacs, especially those at high risk for AIDS.
  • Further research into the mechanisms of trimethoprim-sulfamethoxazole toxicity in this population is recommended.

Related Concept Videos

Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
Hypersensitivity Reactions: Cytolytic Reactions01:01

Hypersensitivity Reactions: Cytolytic Reactions

Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...
Drug toxicity: Idiosyncratic Reactions01:16

Drug toxicity: Idiosyncratic Reactions

Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
Hypersensitivity Reactions: Immune-Complex Reactions01:19

Hypersensitivity Reactions: Immune-Complex Reactions

Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum sickness, a systemic...